针对慢性炎症性呼吸道疾病的干预性肺病学
Han Yang1, Si Chen2,3, Jiayuan Sun1,2,3
1Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Chinese medical journal pulmonary and critical care medicine
|October 15, 2024
概括
干预性肺病学为慢性炎症性呼吸道疾病 (如COPD和喘) 提供了新的最小侵入性治疗方法. 这些程序旨在通过准肺体积,粘液和呼吸道肌肉来改善症状.
科学领域:
- 肺部病理学 肺部病理学
- 干预性肺病学 干预性肺病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性炎症性呼吸道疾病 (CIAD),如COPD,喘和肺气,对全球健康构成重大挑战.
- 最佳的医疗疗法是标准的,但干预性治疗正在成为有价值的补充.
- 最少侵入性手术为精确的干预提供了直接通往气道的机会.
研究的目的:
- 对CIAD进行干预治疗的潜在优势进行审查.
- 讨论针对特定疾病亚型的各种技术.
- 帮助干预性肺病学家选择最佳的患者治疗方法.
主要方法:
- 对CIADs目前的干预技术的审查.
- 根据疾病对手术进行分类 (COPD,喘,肺气,慢性支气管炎).
- 讨论症状改善的作用机制.
主要成果:
- 干预性治疗包括支气管热塑性,肺体积减小 (门,线圈,蒸汽切除),气道绕道,支架安置,脊髓塑性和冷疗法.
- 这些方法旨在减少肺部膨胀,减少粘液,并放松气道光滑肌肉.
- 目前正在为特定的CIAD开发技术,以解决呼吸障碍和过分分泌等症状.
结论:
- 干预性治疗对管理CIADs超出传统医疗疗的承诺.
- 量身定制的方法对于优化COPD,喘和肺气等疾病的结果至关重要.
- 进一步的研究和临床应用可以提高慢性呼吸道疾病的患者护理.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
184
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
184
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
356
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
356
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


